Literature DB >> 17360784

Improved insulin sensitivity by anti-TNFalpha antibody treatment in patients with rheumatic diseases.

Frank C Huvers, Calin Popa, Mihai G Netea, Frank H J van den Hoogen, Cees J Tack.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17360784      PMCID： PMC1856029          DOI： 10.1136/ard.2006.062323

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  9 in total

1.  Improvement of insulin sensitivity in insulin resistant subjects during prolonged treatment with the anti-TNF-alpha antibody infliximab.

Authors:  B Yazdani-Biuki; H Stelzl; H P Brezinschek; J Hermann; T Mueller; P Krippl; W Graninger; T C Wascher
Journal:  Eur J Clin Invest       Date:  2004-09       Impact factor: 4.686

Review 2.  Adipose tissue, adipokines, and inflammation.

Authors:  Giamila Fantuzzi
Journal:  J Allergy Clin Immunol       Date:  2005-05       Impact factor: 10.793

Review 3.  Inflammation, stress, and diabetes.

Authors:  Kathryn E Wellen; Gökhan S Hotamisligil
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

4.  Caffeine can decrease insulin sensitivity in humans.

Authors:  Gerben B Keijzers; Bastiaan E De Galan; Cees J Tack; Paul Smits
Journal:  Diabetes Care       Date:  2002-02       Impact factor: 19.112

5.  Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM.

Authors:  F Ofei; S Hurel; J Newkirk; M Sopwith; R Taylor
Journal:  Diabetes       Date:  1996-07       Impact factor: 9.461

6.  Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function.

Authors:  K T Uysal; S M Wiesbrock; M W Marino; G S Hotamisligil
Journal:  Nature       Date:  1997-10-09       Impact factor: 49.962

7.  Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone.

Authors:  C J Tack; M K Ong; J A Lutterman; P Smits
Journal:  Diabetologia       Date:  1998-05       Impact factor: 10.122

8.  Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis.

Authors:  D N Kiortsis; A K Mavridis; S Vasakos; S N Nikas; A A Drosos
Journal:  Ann Rheum Dis       Date:  2004-09-30       Impact factor: 19.103

9.  Impaired glucose handling in active rheumatoid arthritis: relationship to the secretion of insulin and counter-regulatory hormones.

Authors:  K L Svenson; G Lundqvist; L Wide; R Hällgren
Journal:  Metabolism       Date:  1987-10       Impact factor: 8.694
  9 in total
  27 in total

Review 1.  Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk.

Authors:  Allison B Goldfine; Steven E Shoelson
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

Review 2.  Role of innate and adaptive immunity in obesity-associated metabolic disease.

Authors:  Tracey McLaughlin; Shelley E Ackerman; Lei Shen; Edgar Engleman
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

Review 3.  Metabolic syndrome, insulin resistance, and roles of inflammation--mechanisms and therapeutic targets.

Authors:  Giulio R Romeo; Jongsoon Lee; Steven E Shoelson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-08       Impact factor: 8.311

Review 4.  Targeting inflammation in the treatment of type 2 diabetes: time to start.

Authors:  Marc Y Donath
Journal:  Nat Rev Drug Discov       Date:  2014-05-23       Impact factor: 84.694

Review 5.  Inflammation in the Pathophysiology and Therapy of Cardiometabolic Disease.

Authors:  Marc Y Donath; Daniel T Meier; Marianne Böni-Schnetzler
Journal:  Endocr Rev       Date:  2019-08-01       Impact factor: 19.871

Review 6.  Type 2 diabetes as an inflammatory disease.

Authors:  Marc Y Donath; Steven E Shoelson
Journal:  Nat Rev Immunol       Date:  2011-01-14       Impact factor: 53.106

7.  Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis.

Authors:  Calin Popa; Frank H J van den Hoogen; Timothy R D J Radstake; Mihai G Netea; Agnes E Eijsbouts; Martin den Heijer; Jos W M van der Meer; Piet L C M van Riel; Anton F H Stalenhoef; Pilar Barrera
Journal:  Ann Rheum Dis       Date:  2007-05-01       Impact factor: 19.103

8.  Rheumatoid arthritis: Obesity impairs efficacy of anti-TNF therapy in patients with RA.

Authors:  Miguel A González-Gay; Carlos González-Juanatey
Journal:  Nat Rev Rheumatol       Date:  2012-09-25       Impact factor: 20.543

9.  Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms.

Authors:  Cecilia P Chung; Annette Oeser; Joseph F Solus; Tebeb Gebretsadik; Ayumi Shintani; Ingrid Avalos; Tuulikki Sokka; Paolo Raggi; Theodore Pincus; C Michael Stein
Journal:  Arthritis Rheum       Date:  2008-07

10.  Drugs Used in the Treatment of Rheumatoid Arthritis: Relationship between Current Use and Cardiovascular Risk Factors.

Authors:  Young Hee Rho; Annette Oeser; Cecilia P Chung; Ginger L Milne; C Michael Stein
Journal:  Arch Drug Inf       Date:  2009-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.